NAICS 325414: Biological Product
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

ExioML sector: Chemicals nec
Region: US | Year: 2022
Sector value added: 183879.917188 M EUR | Employment: 2033.54236812 thousand persons
Sector GHG emissions: 125728834468.0 kg CO2 eq | Energy carrier net total: 3186425.50957 TJ | Carbon intensity: 0.6837551179635024

Company: Remel Inc
Remel Inc. manufactures diagnostic products. The Company offers microbiology, parasitology, immunology, serology, mycology, virology, hematology, as well as industrial products, including covering food and beverage, pharmaceutical, and personal care products.